Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has a falling wedge that formed over the last couple weeks that looks like it popped out on Thursday, jumping 2.04, or 6.33, to 34.27, on 868,176 shares traded. That’s not huge volume, but the technicals held up well. It looks like it’s time for it to move up and test 38, and then the low 40’s.
Remark Holdings, Inc. (NASDAQ:MARK) has an interesting pattern. After three days of popping, and then a pullback, it had an inside day on Thursday on lower volume, running up 25 cents, or 2.82%, to 9.11, on 1.24 million shares traded. It has great technicals and a wedge forming. If this wedge pops, I’m going to look for a retest quickly of the 10.75-.80 range. Once it gets through that, targets are 12-12 1/2, and then 14-15.
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) is a recent swing trade of ours that I re-added on Thursday as it broke out of a downward flag. It popped 33 cents, or 6%, to 6.26, on 512,897 shares traded on Thursday. I’m anticipating a breakout, and rush through the 6.65 area, and then we’re looking at 8.00. On a longer-term timeframe, the channels call for a move up toward 12.
uniQure N.V. (NASDAQ:QURE) was up 85 cents, or 5%, to 17.86, on 273,380 shares traded on Thursday. I really like the look of this chart. It appears that it’s four waves up and wave five has started. Resistance is in the 19 zone. If it gets through that, targets are 21 and 25.
On the long side, stocks included Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), Apptio, Inc. (NASDAQ:APTI), Boyd Gaming Corporation (NYSE:BYD), General Cannabis Corp. (OTC:CANN), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Editas Medicine Inc. (NASDAQ:EDIT), Fate Therapeutics, Inc. (NASDAQ:FATE), The Finish Line, Inc. (NASDAQ:FINL), Remark Holdings, Inc. (MARK), Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), uniQure N.V. (QURE), Canopy Growth Corporation (TWMJF), Valeant Pharmaceuticals International Inc (NYSE:VRX), SolarWindow Technologies, Inc. (OTC:WNDW), United States Steel Corp. (NYSE:X), and XOMA Corporation (NASDAQ:XOMA).